Authors:
Bhatnagar, AS
Brodie, AMH
Long, BJ
Evans, DB
Miller, WR
Citation: As. Bhatnagar et al., Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors, J STEROID B, 76(1-5), 2001, pp. 199-202
Authors:
Ru, CJ
Lei, XP
Ling, YZ
Zhang, LH
Hundratta, V
Brodie, AMH
Citation: Cj. Ru et al., Syntheses of some 17-heterocyclic substituted androstene derivatives as inhibitors of human 17 alpha-hydroxylase/C-17,C-20-layse(P450(17 alpha)), CHEM J CH U, 22(6), 2001, pp. 931-935
Citation: Vco. Njar et Amh. Brodie, Inhibitors of 17 alpha-hydroxylase/17,20-lyase (CYP17): Potential agents for the treatment of prostate cancer, CUR PHARM D, 5(3), 1999, pp. 163-180
Citation: Ss. Dehal et al., The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: Potential for drug-druginteraction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy, DRUG META D, 27(3), 1999, pp. 389-394
Authors:
Grigoryev, DN
Long, BJ
Nnane, IP
Njar, VCO
Liu, Y
Brodie, AMH
Citation: Dn. Grigoryev et al., Effects of new 17 alpha-hydroxylase/C-17,C-20-lyase inhibitors on LNCaP prostate cancer cell growth in vitro and in vivo, BR J CANC, 81(4), 1999, pp. 622-630
Authors:
Grigoryev, DN
Kato, K
Njar, VCO
Long, BJ
Ling, YZ
Wang, X
Mohler, J
Brodie, AMH
Citation: Dn. Grigoryev et al., Cytochrome P450c17-expressing Escherichia coli as a first-step screening system for 17 alpha-hydroxylase-C-17,C-20-lyase inhibitors, ANALYT BIOC, 267(2), 1999, pp. 319-330
Authors:
Long, BJ
Tilghman, SL
Yue, W
Thiantanawat, A
Grigoryev, DN
Brodie, AMH
Citation: Bj. Long et al., The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity, J STEROID B, 67(4), 1998, pp. 293-304